1. Home
  2. UTSI vs PASG Comparison

UTSI vs PASG Comparison

Compare UTSI & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

HOLD

Current Price

$2.47

Market Cap

23.7M

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$8.81

Market Cap

28.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTSI
PASG
Founded
1991
2017
Country
China
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
28.3M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
UTSI
PASG
Price
$2.47
$8.81
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$34.50
AVG Volume (30 Days)
3.1K
52.1K
Earning Date
08-29-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,793,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$5.12
52 Week High
$2.94
$20.00

Technical Indicators

Market Signals
Indicator
UTSI
PASG
Relative Strength Index (RSI) 49.05 37.06
Support Level $2.30 $8.39
Resistance Level $2.63 $10.12
Average True Range (ATR) 0.09 1.35
MACD 0.00 -0.34
Stochastic Oscillator 51.91 9.65

Price Performance

Historical Comparison
UTSI
PASG

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: